ArticleBritish journal of cancer2009

Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells.

D D Meira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.